Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Part 1 and 2”

496 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 496 results

Testing effectiveness (Phase 2)Study completedNCT03535168
What this trial is testing

Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients

Who this might be right for
Cough
Bayer 59
Early research (Phase 1)Study completedNCT05712460
What this trial is testing

Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants

Who this might be right for
Respiratory Syncytial Viruses
Pfizer 12
Early research (Phase 1)Study completedNCT03493386
What this trial is testing

Daprodustat Bioequivalence and Food Effect Study

Who this might be right for
Anaemia
GlaxoSmithKline 64
Testing effectiveness (Phase 2)Ended earlyNCT00959946
What this trial is testing

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Who this might be right for
Advanced Breast Cancer (Parts 1 and 2)Advanced Pancreatic Cancer (Part 1)Advanced Colorectal Cancer (Part 1)+2 more
Pfizer 32
Testing effectiveness (Phase 2)Study completedNCT01999582
What this trial is testing

Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

Who this might be right for
AnemiaKidney Failure, Chronic
Celgene 50
Early research (Phase 1)Study completedNCT03720366
What this trial is testing

Perpetrator Drug Interactions of Enasidenib in AML Patients

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 40
Early research (Phase 1)Study completedNCT00935831
What this trial is testing

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Who this might be right for
Kidney Disease
GlaxoSmithKline 12
Early research (Phase 1)Looking for participantsNCT05533372
What this trial is testing

MAD Study of IA-14069

Who this might be right for
HealthyRheumatoid Arthritis
ILAb Co., Ltd. 75
Early research (Phase 1)Study completedNCT01614756
What this trial is testing

A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis

Who this might be right for
Healthy Subjects and Atopic Dermatitis Subjects
Bristol-Myers Squibb 93
Testing effectiveness (Phase 2)Looking for participantsNCT06782373
What this trial is testing

Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

Who this might be right for
VEXASVEXAS Syndrome
Swedish Orphan Biovitrum 78
Early research (Phase 1)Study completedNCT02359045
What this trial is testing

Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed Conditions

Who this might be right for
Relative BioavailabilityAUCCmax+1 more
AstraZeneca 137
Testing effectiveness (Phase 2)Study completedNCT04368988
What this trial is testing

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

Who this might be right for
COVID-19
Novavax 1,419
Early research (Phase 1)Study completedNCT06780254
What this trial is testing

Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers

Who this might be right for
Healthy
Vespina Lifesciences Inc. 58
Early research (Phase 1)Study completedNCT04903509
What this trial is testing

A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide

Who this might be right for
Healthy
Boehringer Ingelheim 95
Testing effectiveness (Phase 2)Study completedNCT04774328
What this trial is testing

Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair

Who this might be right for
Postsurgical Pain
Concentric Analgesics 34
Early research (Phase 1)Looking for participantsNCT07242781
What this trial is testing

Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants

Who this might be right for
Healthy Volunteers
Celgene 42
Early research (Phase 1)Study completedNCT03096756
What this trial is testing

The Safety, Tolerability and Pharmacokinetics of Orally-administered GC4702 in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Galera Therapeutics, Inc. 48
Early research (Phase 1)Study completedNCT02068105
What this trial is testing

ALKS 5461 in Healthy Volunteers

Who this might be right for
Pharmacokinetics
Alkermes, Inc. 104
Early research (Phase 1)Study completedNCT01156077
What this trial is testing

Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients

Who this might be right for
Bacterial Infection
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 20
Post-approval studies (Phase 4)Study completedNCT04085172
What this trial is testing

TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Shire 396
Load More Results